抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Tifcemalimab
All
TD-HV375016_1.jpg
- Catalog： TD-HV375016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： JS004,Icatolimab,CAS:2236068-83-8
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Tifcemalimab
| Catalog No. | TD-HV375016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Chimeric |
| Isotype | IgG4-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | B- and T-lymphocyte attenuator, BTLA, CD272, B- and T-lymphocyte-associated protein |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | Q7Z6A9 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | JS004,Icatolimab,CAS:2236068-83-8 |
| Background | Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Tifcemalimab. |